2017
DOI: 10.1016/j.jddst.2017.05.014
|View full text |Cite
|
Sign up to set email alerts
|

BMP delivery systems for bone regeneration: Healthy vs osteoporotic population. Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0
3

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 114 publications
0
13
0
3
Order By: Relevance
“…Several carriers have been proposed for the delivery of bone active molecules for critical defect healing. A majority of them often involve tedious fabrication strategies, and the preparation in the operating room remains a challenge due to practical reasons (24). The goal of this study was to use a clinically tested CaS/HA biomaterial that could provide an easy-to-implement single-stage platform for the delivery of the bone active molecules such as rhBMP-2 and ZA in a clinically relevant critical bone defect model in rats.…”
Section: Introductionmentioning
confidence: 99%
“…Several carriers have been proposed for the delivery of bone active molecules for critical defect healing. A majority of them often involve tedious fabrication strategies, and the preparation in the operating room remains a challenge due to practical reasons (24). The goal of this study was to use a clinically tested CaS/HA biomaterial that could provide an easy-to-implement single-stage platform for the delivery of the bone active molecules such as rhBMP-2 and ZA in a clinically relevant critical bone defect model in rats.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, the ability to control the release rate of BMP‐2 post‐implantation represents a distinct advantage over existing systems which frequently demonstrate BMP release as a “burst release” immediately following implantation rather than a sustained release over time. This release profile differs greatly from the physiologic processes in normal bone healing and results in the formation of poor quality bone 26 . Slower, more sustained release kinetics are more biologically accurate and are reported to result in an enhanced bone healing response 4,27–29 .…”
Section: Discussionmentioning
confidence: 99%
“…A controlled elution of BMP‐2 for longer time periods is required for optimal bone healing . It is important to note that both in vitro and in vivo release kinetics profiles differ from each other to a great extent because in in vivo the cellular activity, blood circulation, and scaffold degradation, lead to a more pronounced and accelerated release . Commercially, Medtronic has been using a hollow titanium cage filled with rhBMP‐2 adsorbed collagen sponge (trademarked as INFUSE‐ACS) to treat interbody spinal fusions, which shows a burst release of BMP‐2 and >95% of release after 2 weeks of post in vivo implantation .…”
Section: Discussionmentioning
confidence: 99%